TPD52L2

Tumor protein D54 · O43399 · TPD52L2 on Sugi Atlas →

0 patent compounds predicted against TPD52L2, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to TPD52L2 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Gene Expression Profiles in Predicting Chemotherapy Response in Breast Cancer PHASE2COMPLETED
Phase I/II Study of Neoadjuvant Lapatinib in Breast Cancer PHASE1/PHASE2COMPLETED
Bortezomib in Treating Patients With Advanced or Metastatic Sarcoma PHASE2COMPLETED
RAD001 Plus Octreotide Depot in Metastatic or Unresectable Low Grade Neuroendocrine Carcinoma PHASE2COMPLETED
Chemotherapy for Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma PHASE1UNKNOWN
Phase I Study of Oral BAY 1217389 in Combination With Intravenous Paclitaxel PHASE1COMPLETED
A Phase I Study of Systemic Gene Therapy With SGT-94 in Patients With Solid Tumors PHASE1COMPLETED
First-in-human Study of Oral TP-0184 in Patients With Advanced Solid Tumors PHASE1COMPLETED
Study of TP-3654 in Patients With Advanced Solid Tumors PHASE1COMPLETED
An Exploratory Biomarker Study of ARQ 501 in Patients With Advanced Solid Tumors PHASE1COMPLETED
A Study of BL-M07D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Low Expression Breast Cancer and Other Solid Tumors PHASE1RECRUITING
Safety and Efficacy Study of ALT-801 to Treat Progressive Metastatic Malignancies PHASE1COMPLETED
Bristol-Myers Squibb Dasatinib Src Inhibition in Endometrial Cancer EARLY_PHASE1COMPLETED
Genetic Investigation of Solid Tumors Cohort nanCOMPLETED
Studying Tissue Samples From Patients With Stage II Colon Cancer Treated on Clinical Trial CLB-9581 nanCOMPLETED
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development nanCOMPLETED
Magnetic Resonance Imaging for Improving Knowledge of Brain Tumor Biology in Patients With Resectable Glioblastoma nanRECRUITING
Establishing Radiolabelled PSMA as a Target for Glioma Treatment nanNOT_YET_RECRUITING
Donation of Post Mortem Tumor Tissues nanCOMPLETED
Effect of Adenovirus E1A Oncogene on DNA Replication Dynamics nanUNKNOWN
Patient-derived Glioma Stem Cell Organoids nanACTIVE_NOT_RECRUITING
Validation of 70-gene MammaPrint Profile in Japanese Population nanCOMPLETED
Profiles of Expression in HPV+ Versus HPV Head and Neck Cancers nanUNKNOWN
Cohort of Tumors With POLE/D1 Mutation nanRECRUITING
Biomarkers in Patients With Diffuse Large B-Cell Lymphoma Treated With Combination Chemotherapy With or Without Rituximab nanCOMPLETED
Prognostic Markers of Gynecologic Cancers nanCOMPLETED
The Oncopanel Pilot (TOP) Study nanCOMPLETED
Molecular and Immunohistochemical Profiling of Tumors in Patients With Parathyroid Tumors nanRECRUITING
A-protein Levels in Adult and Pediatric Brain Tumor Patients nanCOMPLETED
Studying Protein Expression in Tissue Samples From Younger Patients With Rhabdomyosarcoma nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a TPD52L2 binder may also engage these)

ProteinNameSimilarity
Q6PCT3 0.996 Q6PCT3 →
Q95212 0.993 Q95212 →
Q5RCT1 0.992 Q5RCT1 →
Q9CYZ2 0.990 Q9CYZ2 →
Q16890 0.985 Q16890 →
P55327 0.980 P55327 →
Q9I8F4 0.978 Q9I8F4 →
O54818 0.971 O54818 →
Q62393 0.951 Q62393 →
Q9CPQ3 0.931 Q9CPQ3 →
Q6ZVM7 0.921 Q6ZVM7 →
Q5SRX1 0.920 Q5SRX1 →
TIMM44 Mitochondrial import inner membrane translocase subunit TIM44 0.918 landscape →
Q75Q41 0.917 Q75Q41 →
TOMM22 Mitochondrial import receptor subunit TOM22 homolog 0.913 landscape →
P84060 0.912 P84060 →
F1N5S9 0.912 F1N5S9 →
Q4R3C7 0.912 Q4R3C7 →
A5D7H2 0.911 A5D7H2 →
O60941 0.909 O60941 →
Q9DB70 0.909 Q9DB70 →
Q5BJS4 0.909 Q5BJS4 →
A6QPI6 0.909 A6QPI6 →
Q8K1Z0 0.908 Q8K1Z0 →
Q9ERG2 0.907 Q9ERG2 →
Q9D8B3 0.907 Q9D8B3 →
Q5ZJB7 0.907 Q5ZJB7 →
Q9Y4J8 0.907 Q9Y4J8 →
Q80TY0 0.907 Q80TY0 →
F1QH17 0.907 F1QH17 →